Table 2.
Hyperinsulinemia at baseline is positively associated with the development of many conditions and diseases at follow-up.
| Reference No | Type of Study | |
|---|---|---|
| Obesity | 4 | Prospective, observational |
| 5 | Prospective, observational | |
| 116 | Prospective, observational | |
| Impaired Glucose Tolerance | 119 | Prospective, observational |
| 126 | Prospective, observational | |
| 127 | Prospective, observational | |
| Type 2 Diabetes | 9 | Prospective, observational |
| 84 | Prospective, observational | |
| 86 | Prospective, observational | |
| 120 | Prospective, observational | |
| 124 | Prospective, observational | |
| 127 | Prospective, observational | |
| Cardiovascular Disease | 1 | Prospective, observational |
| 2 | Prospective, observational | |
| 3 | Prospective, observational | |
| 130 | Prospective, observational | |
| 131 | Prospective, observational | |
| 132 | Prospective, observational | |
| Cancer | ||
| Liver Cancer | 6 | Prospective, observational |
| Colorectal Cancer | 8 | Prospective, observational |
| Colorectal Cancer | 145 | Prospective, observational |
| Pancreas | 145 | Prospective, observational |
| Breast Cancer | 146 | Prospective, observational |
| Cancer Mortality | 7 | Prospective, observational |
| Decreased Survival | 164 | Prospective, observational |